CN Stock MarketDetailed Quotes

600055 Beijing Wandong Medical Technology

Watchlist
  • 16.79
  • -0.60-3.45%
Market Closed Dec 13 15:00 CST
11.80BMarket Cap64.08P/E (TTM)

Beijing Wandong Medical Technology Key Stats

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
18.07%1.09B
17.79%700.09M
20.94%308.5M
10.30%1.24B
26.36%925.79M
30.19%594.33M
21.12%255.08M
-3.02%1.12B
-8.50%732.66M
-7.74%456.52M
Operating revenue
18.07%1.09B
17.79%700.09M
20.94%308.5M
10.30%1.24B
26.36%925.79M
30.19%594.33M
21.12%255.08M
-3.02%1.12B
-8.50%732.66M
-7.74%456.52M
Other operating revenue
----
16.04%28.36M
----
39.65%75.73M
----
2.34%24.44M
----
0.14%54.23M
----
11.95%23.88M
Total operating cost
17.85%973.08M
15.64%611.62M
19.44%277.82M
16.23%1.11B
32.14%825.71M
32.67%528.91M
22.00%232.59M
-3.55%951.61M
-8.81%624.9M
-5.72%398.68M
Operating cost
24.65%674.08M
20.17%423.3M
26.08%192.94M
13.72%712.58M
32.60%540.76M
38.32%352.26M
38.87%153.03M
0.03%626.61M
-2.12%407.82M
-0.38%254.67M
Operating tax surcharges
14.62%8.43M
5.81%6.21M
-50.66%761.83K
-21.07%11.86M
-7.77%7.35M
-0.67%5.87M
1.73%1.54M
0.46%15.02M
-6.81%7.97M
-6.37%5.91M
Operating expense
-0.23%163.37M
-5.83%99.98M
3.98%49.63M
27.98%223.26M
38.96%163.75M
34.52%106.16M
21.33%47.73M
-5.93%174.46M
-17.14%117.83M
-10.69%78.92M
Administration expense
-1.88%57.19M
-5.99%38.12M
-3.67%17.95M
19.32%80.77M
14.37%58.29M
17.01%40.55M
-1.51%18.63M
-4.05%67.69M
-0.10%50.96M
-7.76%34.65M
Financial expense
16.05%-45.51M
13.66%-34.97M
-8.52%-18.66M
-14.42%-80.01M
-24.32%-54.21M
-63.20%-40.5M
-311.88%-17.19M
-214.34%-69.92M
-653.32%-43.61M
-682.87%-24.82M
-Interest expense (Financial expense)
-28.27%408.04K
-28.27%282.24K
----
-14.40%1.25M
-1.15%568.85K
13.30%393.47K
--98.14K
-2.61%1.47M
--575.49K
--347.27K
-Interest Income (Financial expense)
4.01%-48.87M
5.31%-34.31M
-0.16%-18.72M
-31.42%-81.13M
-54.45%-50.91M
-87.87%-36.23M
-304.51%-18.69M
-136.48%-61.73M
-409.60%-32.96M
-384.52%-19.28M
Research and development
5.23%115.52M
22.33%78.99M
21.98%35.19M
14.38%157.56M
30.82%109.77M
30.86%64.57M
16.04%28.85M
23.57%137.76M
15.47%83.91M
29.26%49.34M
Credit Impairment Loss
-18.27%2.38M
-18.27%2.38M
----
67.58%-7.45M
143.95%2.91M
143.95%2.91M
5,571.88%85.24K
-33.42%-22.99M
-50.79%-6.62M
-51.18%-6.62M
Asset Impairment Loss
-421.39%-4.87K
-421.39%-4.87K
----
55.09%-2.11M
48.53%1.52K
48.53%1.52K
----
31.62%-4.7M
-99.86%1.02K
-99.60%1.02K
Other net revenue
-58.46%19.19M
-53.06%13.42M
-46.93%6.88M
260.20%82.68M
84.90%46.2M
117.59%28.58M
23.04%12.97M
-41.38%22.95M
-31.06%24.99M
-54.57%13.14M
Fair value change income
2,114.76%1.19M
1,358.72%781.48K
----
1,096.13%34.59M
100.88%53.57K
101.02%53.57K
101.17%53.57K
-61.98%-3.47M
-1,677.57%-6.11M
-1,421.32%-5.23M
Invest income
-44.37%2.92M
-12.48%1.48M
-77.01%131.43K
-61.25%8.29M
-63.30%5.24M
-82.14%1.69M
-92.13%571.64K
1.93%21.39M
12.92%14.29M
-18.15%9.48M
-Including: Investment income associates
116.03%148.28K
76.57%-111.34K
111.03%28.28K
-951.31%-2.05M
-518.24%-925.01K
-400.49%-475.13K
-535.08%-256.5K
-149.64%-195.21K
-66.50%221.17K
-70.67%158.12K
Asset deal income
2,268.30%26.63K
-57.79%24.51K
----
83.13%-301.52K
100.47%1.12K
126.55%58.07K
113.74%38.52K
-648.78%-1.79M
-53.80%-241.15K
-50.67%-218.72K
Other revenue
-66.60%12.69M
-63.32%8.75M
-44.75%6.75M
43.92%49.66M
60.52%37.99M
51.84%23.87M
50.59%12.22M
-22.72%34.51M
-14.65%23.67M
-28.35%15.72M
Operating profit
-4.84%139.2M
8.38%101.88M
5.93%37.56M
10.79%213.33M
10.20%146.28M
32.44%94M
16.32%35.46M
-7.76%192.55M
-12.47%132.74M
-29.63%70.98M
Add:Non operating Income
9,131.33%1.05M
13,413.89%1.46M
----
4,150.52%866.89K
18,925.67%11.42K
17,925.67%10.82K
--3.46K
883.19%20.39K
-97.11%60
-97.11%60
Less:Non operating expense
112.24%1.11M
3,067.60%941.89K
85.22%21.41K
564.09%860.99K
--523.48K
--29.74K
--11.56K
-91.47%129.65K
----
----
Total profit
-4.55%139.14M
8.95%102.4M
5.89%37.54M
10.86%213.33M
9.81%145.77M
32.41%93.99M
16.30%35.45M
-7.14%192.44M
-12.35%132.74M
-29.49%70.98M
Less:Income tax cost
-5.97%22.51M
3.43%16.9M
-41.74%3.37M
10.41%22.52M
-18.70%23.94M
43.10%16.34M
13.28%5.78M
-24.33%20.4M
-7.64%29.45M
-36.84%11.42M
Net profit
-4.27%116.63M
10.12%85.5M
15.16%34.17M
10.91%190.81M
17.94%121.82M
30.36%77.64M
16.90%29.67M
-4.56%172.04M
-13.61%103.29M
-27.88%59.56M
Net profit from continuing operation
-4.27%116.63M
10.12%85.5M
15.16%34.17M
10.91%190.81M
17.94%121.82M
30.36%77.64M
16.90%29.67M
-4.56%172.04M
-13.61%103.29M
-27.88%59.56M
Less:Minority Profit
-45.55%892.92K
-52.78%756.27K
219.72%915.58K
168.18%2.27M
873.45%1.64M
545.42%1.6M
-201.96%-764.8K
-13.73%-3.33M
122.55%168.46K
139.42%248.14K
Net profit of parent company owners
-3.70%115.73M
11.44%84.74M
9.26%33.26M
7.51%188.54M
16.54%120.18M
28.21%76.04M
23.57%30.44M
-4.27%175.37M
-14.29%103.13M
-28.72%59.31M
Earning per share
Basic earning per share
-3.51%0.165
9.09%0.12
9.30%0.047
0.00%0.27
6.88%0.171
10.00%0.11
-6.52%0.043
-20.59%0.27
-28.25%0.16
-33.33%0.1
Diluted earning per share
-3.51%0.165
9.09%0.12
9.30%0.047
0.00%0.27
6.88%0.171
10.00%0.11
-6.52%0.043
-20.59%0.27
-28.25%0.16
-33.33%0.1
Other composite income
-100.25%-1.35M
-48.41%-674.9K
Other composite income of parent company owners
----
----
----
-100.25%-1.35M
----
----
----
-48.41%-674.9K
----
----
Total composite income
-4.27%116.63M
10.12%85.5M
15.16%34.17M
10.56%189.46M
17.94%121.82M
30.36%77.64M
16.90%29.67M
-4.70%171.36M
-13.61%103.29M
-27.88%59.56M
Total composite income of parent company owners
-3.70%115.73M
11.44%84.74M
9.26%33.26M
7.15%187.19M
16.54%120.18M
28.21%76.04M
23.57%30.44M
-4.40%174.69M
-14.29%103.13M
-28.72%59.31M
Total composite income of minority owners
-45.55%892.92K
-52.78%756.27K
219.72%915.58K
168.18%2.27M
873.45%1.64M
545.42%1.6M
-201.96%-764.8K
-13.73%-3.33M
122.55%168.46K
139.42%248.14K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 18.07%1.09B17.79%700.09M20.94%308.5M10.30%1.24B26.36%925.79M30.19%594.33M21.12%255.08M-3.02%1.12B-8.50%732.66M-7.74%456.52M
Operating revenue 18.07%1.09B17.79%700.09M20.94%308.5M10.30%1.24B26.36%925.79M30.19%594.33M21.12%255.08M-3.02%1.12B-8.50%732.66M-7.74%456.52M
Other operating revenue ----16.04%28.36M----39.65%75.73M----2.34%24.44M----0.14%54.23M----11.95%23.88M
Total operating cost 17.85%973.08M15.64%611.62M19.44%277.82M16.23%1.11B32.14%825.71M32.67%528.91M22.00%232.59M-3.55%951.61M-8.81%624.9M-5.72%398.68M
Operating cost 24.65%674.08M20.17%423.3M26.08%192.94M13.72%712.58M32.60%540.76M38.32%352.26M38.87%153.03M0.03%626.61M-2.12%407.82M-0.38%254.67M
Operating tax surcharges 14.62%8.43M5.81%6.21M-50.66%761.83K-21.07%11.86M-7.77%7.35M-0.67%5.87M1.73%1.54M0.46%15.02M-6.81%7.97M-6.37%5.91M
Operating expense -0.23%163.37M-5.83%99.98M3.98%49.63M27.98%223.26M38.96%163.75M34.52%106.16M21.33%47.73M-5.93%174.46M-17.14%117.83M-10.69%78.92M
Administration expense -1.88%57.19M-5.99%38.12M-3.67%17.95M19.32%80.77M14.37%58.29M17.01%40.55M-1.51%18.63M-4.05%67.69M-0.10%50.96M-7.76%34.65M
Financial expense 16.05%-45.51M13.66%-34.97M-8.52%-18.66M-14.42%-80.01M-24.32%-54.21M-63.20%-40.5M-311.88%-17.19M-214.34%-69.92M-653.32%-43.61M-682.87%-24.82M
-Interest expense (Financial expense) -28.27%408.04K-28.27%282.24K-----14.40%1.25M-1.15%568.85K13.30%393.47K--98.14K-2.61%1.47M--575.49K--347.27K
-Interest Income (Financial expense) 4.01%-48.87M5.31%-34.31M-0.16%-18.72M-31.42%-81.13M-54.45%-50.91M-87.87%-36.23M-304.51%-18.69M-136.48%-61.73M-409.60%-32.96M-384.52%-19.28M
Research and development 5.23%115.52M22.33%78.99M21.98%35.19M14.38%157.56M30.82%109.77M30.86%64.57M16.04%28.85M23.57%137.76M15.47%83.91M29.26%49.34M
Credit Impairment Loss -18.27%2.38M-18.27%2.38M----67.58%-7.45M143.95%2.91M143.95%2.91M5,571.88%85.24K-33.42%-22.99M-50.79%-6.62M-51.18%-6.62M
Asset Impairment Loss -421.39%-4.87K-421.39%-4.87K----55.09%-2.11M48.53%1.52K48.53%1.52K----31.62%-4.7M-99.86%1.02K-99.60%1.02K
Other net revenue -58.46%19.19M-53.06%13.42M-46.93%6.88M260.20%82.68M84.90%46.2M117.59%28.58M23.04%12.97M-41.38%22.95M-31.06%24.99M-54.57%13.14M
Fair value change income 2,114.76%1.19M1,358.72%781.48K----1,096.13%34.59M100.88%53.57K101.02%53.57K101.17%53.57K-61.98%-3.47M-1,677.57%-6.11M-1,421.32%-5.23M
Invest income -44.37%2.92M-12.48%1.48M-77.01%131.43K-61.25%8.29M-63.30%5.24M-82.14%1.69M-92.13%571.64K1.93%21.39M12.92%14.29M-18.15%9.48M
-Including: Investment income associates 116.03%148.28K76.57%-111.34K111.03%28.28K-951.31%-2.05M-518.24%-925.01K-400.49%-475.13K-535.08%-256.5K-149.64%-195.21K-66.50%221.17K-70.67%158.12K
Asset deal income 2,268.30%26.63K-57.79%24.51K----83.13%-301.52K100.47%1.12K126.55%58.07K113.74%38.52K-648.78%-1.79M-53.80%-241.15K-50.67%-218.72K
Other revenue -66.60%12.69M-63.32%8.75M-44.75%6.75M43.92%49.66M60.52%37.99M51.84%23.87M50.59%12.22M-22.72%34.51M-14.65%23.67M-28.35%15.72M
Operating profit -4.84%139.2M8.38%101.88M5.93%37.56M10.79%213.33M10.20%146.28M32.44%94M16.32%35.46M-7.76%192.55M-12.47%132.74M-29.63%70.98M
Add:Non operating Income 9,131.33%1.05M13,413.89%1.46M----4,150.52%866.89K18,925.67%11.42K17,925.67%10.82K--3.46K883.19%20.39K-97.11%60-97.11%60
Less:Non operating expense 112.24%1.11M3,067.60%941.89K85.22%21.41K564.09%860.99K--523.48K--29.74K--11.56K-91.47%129.65K--------
Total profit -4.55%139.14M8.95%102.4M5.89%37.54M10.86%213.33M9.81%145.77M32.41%93.99M16.30%35.45M-7.14%192.44M-12.35%132.74M-29.49%70.98M
Less:Income tax cost -5.97%22.51M3.43%16.9M-41.74%3.37M10.41%22.52M-18.70%23.94M43.10%16.34M13.28%5.78M-24.33%20.4M-7.64%29.45M-36.84%11.42M
Net profit -4.27%116.63M10.12%85.5M15.16%34.17M10.91%190.81M17.94%121.82M30.36%77.64M16.90%29.67M-4.56%172.04M-13.61%103.29M-27.88%59.56M
Net profit from continuing operation -4.27%116.63M10.12%85.5M15.16%34.17M10.91%190.81M17.94%121.82M30.36%77.64M16.90%29.67M-4.56%172.04M-13.61%103.29M-27.88%59.56M
Less:Minority Profit -45.55%892.92K-52.78%756.27K219.72%915.58K168.18%2.27M873.45%1.64M545.42%1.6M-201.96%-764.8K-13.73%-3.33M122.55%168.46K139.42%248.14K
Net profit of parent company owners -3.70%115.73M11.44%84.74M9.26%33.26M7.51%188.54M16.54%120.18M28.21%76.04M23.57%30.44M-4.27%175.37M-14.29%103.13M-28.72%59.31M
Earning per share
Basic earning per share -3.51%0.1659.09%0.129.30%0.0470.00%0.276.88%0.17110.00%0.11-6.52%0.043-20.59%0.27-28.25%0.16-33.33%0.1
Diluted earning per share -3.51%0.1659.09%0.129.30%0.0470.00%0.276.88%0.17110.00%0.11-6.52%0.043-20.59%0.27-28.25%0.16-33.33%0.1
Other composite income -100.25%-1.35M-48.41%-674.9K
Other composite income of parent company owners -------------100.25%-1.35M-------------48.41%-674.9K--------
Total composite income -4.27%116.63M10.12%85.5M15.16%34.17M10.56%189.46M17.94%121.82M30.36%77.64M16.90%29.67M-4.70%171.36M-13.61%103.29M-27.88%59.56M
Total composite income of parent company owners -3.70%115.73M11.44%84.74M9.26%33.26M7.15%187.19M16.54%120.18M28.21%76.04M23.57%30.44M-4.40%174.69M-14.29%103.13M-28.72%59.31M
Total composite income of minority owners -45.55%892.92K-52.78%756.27K219.72%915.58K168.18%2.27M873.45%1.64M545.42%1.6M-201.96%-764.8K-13.73%-3.33M122.55%168.46K139.42%248.14K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.